Cell Biotech Co., Ltd. (KOSDAQ: 049960)
South Korea
· Delayed Price · Currency is KRW 13,670
+120 (0.89%)
Oct 11, 2024, 9:00 AM KST
Cell Biotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 54,097 | 53,787 | 50,526 | 46,873 | 45,582 | 45,960 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | -0 | Upgrade
|
| Revenue | 54,097 | 53,787 | 50,526 | 46,873 | 45,582 | 45,960 | Upgrade
|
| Revenue Growth (YoY) | 5.03% | 6.46% | 7.79% | 2.83% | -0.82% | -26.52% | Upgrade
|
| Cost of Revenue | 15,427 | 15,139 | 12,854 | 11,399 | 11,309 | 10,990 | Upgrade
|
| Gross Profit | 38,671 | 38,649 | 37,672 | 35,475 | 34,273 | 34,969 | Upgrade
|
| Selling, General & Admin | 23,927 | 29,845 | 25,278 | 21,988 | 24,639 | 23,704 | Upgrade
|
| Research & Development | 4,070 | 3,725 | 3,559 | 3,500 | 3,329 | 3,704 | Upgrade
|
| Other Operating Expenses | 242.67 | 221.45 | 249.55 | 207.87 | 179.76 | 176.59 | Upgrade
|
| Operating Expenses | 30,894 | 36,453 | 31,621 | 28,218 | 30,606 | 29,175 | Upgrade
|
| Operating Income | 7,777 | 2,195 | 6,051 | 7,257 | 3,667 | 5,795 | Upgrade
|
| Interest Expense | -74.14 | -61.95 | -37.49 | -42.48 | -49.28 | -53.63 | Upgrade
|
| Interest & Investment Income | 3,089 | 3,180 | 860.17 | 1,103 | 700.01 | 846.06 | Upgrade
|
| Earnings From Equity Investments | -82.2 | -82.2 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 2,524 | 698.5 | 2,990 | 3,325 | -2,246 | 1,648 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,074 | 1,162 | 309.01 | 306.97 | 372.3 | -203.22 | Upgrade
|
| EBT Excluding Unusual Items | 14,307 | 7,092 | 10,173 | 11,950 | 2,444 | 8,032 | Upgrade
|
| Gain (Loss) on Sale of Investments | -164.97 | -211.19 | - | 111.68 | -50.69 | 250.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.2 | -0.26 | -0.91 | 29.05 | 9.48 | 24.68 | Upgrade
|
| Pretax Income | 14,141 | 6,880 | 10,172 | 12,090 | 2,402 | 8,307 | Upgrade
|
| Income Tax Expense | 1,175 | 576.36 | 1,891 | 1,707 | -786.7 | 1,076 | Upgrade
|
| Net Income | 12,966 | 6,304 | 8,281 | 10,383 | 3,189 | 7,231 | Upgrade
|
| Net Income to Common | 12,966 | 6,304 | 8,281 | 10,383 | 3,189 | 7,231 | Upgrade
|
| Net Income Growth | 373.95% | -23.87% | -20.25% | 225.58% | -55.90% | -62.70% | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | -0.26% | -0.73% | -2.50% | -0.32% | -4.25% | -1.26% | Upgrade
|
| EPS (Basic) | 1893.49 | 921.07 | 1201.04 | 1468.32 | 449.56 | 975.95 | Upgrade
|
| EPS (Diluted) | 1893.42 | 921.00 | 1201.00 | 1468.00 | 449.56 | 975.95 | Upgrade
|
| EPS Growth | 375.15% | -23.31% | -18.19% | 226.54% | -53.94% | -62.22% | Upgrade
|
| Free Cash Flow | 17,575 | 6,264 | 10,445 | 14,044 | 6,485 | 763.21 | Upgrade
|
| Free Cash Flow Per Share | 2566.47 | 915.24 | 1515.03 | 1985.94 | 914.17 | 103.01 | Upgrade
|
| Dividend Per Share | 450.000 | 450.000 | 450.000 | 450.000 | 450.000 | 600.000 | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | 0% | -25.00% | 0% | Upgrade
|
| Gross Margin | 71.48% | 71.85% | 74.56% | 75.68% | 75.19% | 76.09% | Upgrade
|
| Operating Margin | 14.38% | 4.08% | 11.98% | 15.48% | 8.05% | 12.61% | Upgrade
|
| Profit Margin | 23.97% | 11.72% | 16.39% | 22.15% | 7.00% | 15.73% | Upgrade
|
| Free Cash Flow Margin | 32.49% | 11.65% | 20.67% | 29.96% | 14.23% | 1.66% | Upgrade
|
| EBITDA | 11,710 | 6,100 | 9,689 | 11,046 | 7,352 | 8,415 | Upgrade
|
| EBITDA Margin | 21.65% | 11.34% | 19.18% | 23.56% | 16.13% | 18.31% | Upgrade
|
| D&A For EBITDA | 3,934 | 3,904 | 3,638 | 3,789 | 3,685 | 2,621 | Upgrade
|
| EBIT | 7,777 | 2,195 | 6,051 | 7,257 | 3,667 | 5,795 | Upgrade
|
| EBIT Margin | 14.37% | 4.08% | 11.98% | 15.48% | 8.05% | 12.61% | Upgrade
|
| Effective Tax Rate | 8.31% | 8.38% | 18.59% | 14.12% | - | 12.95% | Upgrade
|
| Advertising Expenses | - | 11,977 | 9,134 | 6,632 | 6,817 | 5,324 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.